Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Dana-Farber Cancer Institute
Boston, MA 02215
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2014 - 2015
Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
Government Medical College ChandigrahClass of 2009
Certifications & Licensure
MA State Medical License 2015 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsMutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting.Aurel Prosz, Pranshu Sahgal, Brandon M Huffman, Zsofia Sztupinszki, Clare X Morris
NPJ Precision Oncology. 2024-04-08 - 29 citationsSecondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinoma.James M Cleary, Betty Rouaisnel, Antoine Daina, Srivatsan Raghavan, Lauren A Roller
NPJ Precision Oncology. 2022-09-02 - 215 citationsAKT/FOXO Signaling Enforces Reversible Differentiation Blockade in Myeloid LeukemiasStephen M. Sykes, Steven W. Lane, Lars Bullinger, Demetrios Kalaitzidis, Rushdia Z. Yusuf
Cell. 2011-09-02
Press Mentions
Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer in TrialMarch 14th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
